The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Casein kinase 2 (CK2) is a Ser/Thr protein kinase.
• CK2 plays a role in cell survival and tumor progression.
• CK2 is a target for cancer therapy.

Purpose of the Study:

• To determine the crystal structure of CK2 in complex with novel inhibitors.
• To understand the binding interactions of tetrabromobenzimidazole derivatives with CK2.
• To identify key structural features responsible for CK2 inhibitor selectivity.

Main Methods:

• X-ray crystallography to determine protein-ligand complex structures.
• Enzyme inhibition assays to determine inhibitor potency (K(i) values).
• Comparative structural analysis of CK2-inhibitor complexes.

Main Results:

• Three new crystal structures of CK2 complexes with tetrabromobenzimidazole derivatives were determined.
• Inhibitors displayed K(i) values in the range of 0.15–0.30 microM.
• Conserved water molecules and specific residues (Lys68, Ile66, Ile174) in the ATP-binding site were identified as critical for ligand binding and selectivity.

Conclusions:

• Tetrabromobenzimidazole derivatives are potent CK2 inhibitors.
• Conserved water molecules and unique CK2 residues dictate ligand binding and selectivity.
• Structural insights can guide the design of more selective CK2 inhibitors.